Non-Steroidal Anti-Inflammatory Drug-Induced Gastro-Duodenal Toxicity

about

Non-Steroidal Anti-Inflammatory Drug-Induced Gastro-Duodenal Toxicity

Item

http://www.wikidata.org/entity/Q57169425

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2010

@uk

name

Non-Steroidal Anti-Inflammatory Drug-Induced Gastro-Duodenal Toxicity

@en

Non-Steroidal Anti-Inflammatory Drug-Induced Gastro-Duodenal Toxicity

@nl

type

Item

label

Non-Steroidal Anti-Inflammatory Drug-Induced Gastro-Duodenal Toxicity

@en

Non-Steroidal Anti-Inflammatory Drug-Induced Gastro-Duodenal Toxicity

@nl

prefLabel

Non-Steroidal Anti-Inflammatory Drug-Induced Gastro-Duodenal Toxicity

@en

Non-Steroidal Anti-Inflammatory Drug-Induced Gastro-Duodenal Toxicity

@nl

P1476

Non-Steroidal Anti-Inflammatory Drug-Induced Gastro-Duodenal Toxicity

@en

P2093

Alaa Rostom

http://www.w3.org/2001/XMLSchema#string

Catherine Dubé

http://www.w3.org/2001/XMLSchema#string

Emilie Jolicoeur

http://www.w3.org/2001/XMLSchema#string

George Wells

http://www.w3.org/2001/XMLSchema#string

Katherine Muir

http://www.w3.org/2001/XMLSchema#string

Michel Boucher

http://www.w3.org/2001/XMLSchema#string

P2860

Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273].

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

Cyclooxygenase-2 expression and inhibition in atherothrombosis

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal

P304

139-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/9781444314403.CH7

http://www.w3.org/2001/XMLSchema#string

P50

Peter Tugwell

P577

2010-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime